Olivier Hermine MD, PhD

Olivier Hermine is a Professor in hematology at the Paris-Descartes University, head of the hematological department at the Necker-Enfant maladies hospital, and leader of the CALYM team “Molecular Mechanisms of Hematologic Disorders and Therapeutic Implications” at the Imagine institute Inserm U 116 CNRS ERL 8654. He is also the coordinator of the Reference Center for mastocytosis (CeRemast).

His research interests include lymphoproliferation linked to the hepatitis C virus, mantle cell lymphomas, and regulation of erythropoiesis. He is a co-founder and member of the scientific committees of biotech companies: AB Science for the development of tyrosine kinase inhibitors and Inatherys for the development of monoclonal antibodies.